- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 19-03-2026: Press Release
19-03-2026 | 08:34 am
19-03-2026 | 08:34 am
Glenmark secured US approval for its OTC nasal spray, tapping into a $384.7 million market. This strategic launch marks the company's entry into the US over-the-counter nasal spray segment, signaling a new growth avenue.
No comments yet. Be the first to comment!